Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine for Acute Painful Crisis in Sickle Cell Disease Patients: Prospective Randomized Control Trial

NCT03431285 is registered in ClinicalTrials.gov with Imam Abdulrahman Bin Faisal University as lead sponsor.

NCT NCT03431285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03431285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine for Acute Painful Crisis in Sickle Cell Disease Patients: Prospective Randomized Control Trial
Lead sponsor
Imam Abdulrahman Bin Faisal University
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2018
Completion date
February 1, 2019
Enrollment
278 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell crisis